This year’s poster, which focuses on KRAS mutations in patients with Pancreatic Cancer, was published in partnership with physicians from several top-class institutions such as Cedars Sinai, Johns Hopkins and the Cleveland Clinic. The Perthera Precision Oncology Platform was utilized in the study to provide structured, curated clinical outcomes data and ranked, therapeutic recommendations to empower clinical researchers and physicians to make significant strides in the improvement of cancer care.
Click here to be linked to the official ASCO Virtual Annual Conference 2020 poster presentation page, or click on the poster below to download a copy of our poster!